Congenital Adrenal Hyperplasia studies recruiting patients need your help. Receive premium care & cutting edge treatments by enrolling in clinical trials today.

Top 10 Congenital Adrenal Hyperplasia Trials [2022 Studies] | Power

Congenital Adrenal Hyperplasia Clinical Trials

Congenital Adrenal Hyperplasia studies recruiting patients for novel treatments. Filter by phase, distance, and inclusion criteria to find your perfect clinical trial.

This phase III study is an open-label extension study to be conducted at approximately 36 investigational sites across 3 countries. The study will evaluate the long-term safety and tolerability of Chronocort in participants aged 16 years and over when used as treatment for Congenital Adrenal Hyperplasia (CAH).

Long-term Safety Study of Chronocort in the Treatment of Participants With Congenital Adrenal Hyperplasia

This study is a randomized, double-blind, active-controlled, phase III study of Chronocort® compared with immediate-release hydrocortisone replacement therapy in participants aged 16 years and over with Congenital Adrenal Hyperplasia.

Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia

This study is evaluating whether Chronocort® is more effective than immediate-release hydrocortisone replacement therapy in people with Congenital Adrenal Hyperplasia.

If someone gives less then ⭐⭐⭐⭐⭐ something is wrong. This is the best resort, I mean hospital I have ever been to. Like, omg, its unreal. The staff is amazing. The doctors are exceptional. The food is on point. The facility is breathtaking. My only complaint is, its way too big f u are a patient. I love it but I got lost soooo many times but there was always someone there to put me back on track. Wish there was more governmental fynding ding for the endocrine department and Cushings research. Other then that. The only thing that would make this place better is to add Mediterranean food to the menu and put in a bowling aleey. Lol.other then that I love it.

the only organization in the pharmacy of the clinical center is what time to report to work. other than that, there are no distinct roles or jobs/responsibilities - just a "get a done" attitude. during huddles, the Service Chief of Pharmacy Operations (wafa samara) threw medications on the floor claiming they were expired (they were not), told the pharmacy if we continue making any mistakes or get a error reported by us she will write us up and escalate to HR, and that she was so upset by the pharmacy that she "would not even take her sick mother here." the Chief of the Pharmacy Department (majid tanas) was made aware and did absolutely nothing. management claims to have an open door policy, but all managers doors are locked with papers taped to windows of their doors. they do not open the door when you knock or call their phone. they also allowed pharmacists that they had a particular relationship with to work m-f 7am-3:30p, with no weekends or holidays while the rest had to fill in the gaps on the schedule. very toxic environment,would not recommend. 13 pharmacy personnel left within a six month period. please google nih pharmacy washington post. also, parking is horrible - be prepared to pay $12/day - that is unless you were favorited by management and received a parking pass.

Staff is very professional and building is very clean

It is listed here as a hospital which is open 24 hours. Beware, it is not! As we drove up to the gate with a medical emergency (severe dog bite), the lady which answered the phone was extremely rude and unprofessional. When I asked to speak to a supervisor, she claimed that she was the supervisor, and made it clear (in a passive aggressive way) that she was not interested in updating the research center's description online. Do not go here if you need to get to a hospital! Misleading description.

I'm a medical professional myself for an unaffiliated organization, and I chose this place be an inpatient for my rare disease. The nursing staff and other supporting disciplines for inpatients are incredible—responsive, compassionate and encouraging—and most importantly, they take the time to treat each patient like an individual human. My specialty team is among, if not THE, most knowledgeable in the world about my condition. The amenities are excellent; I've been particularly enjoying the library, but there's also art, entertainment, a relaxation room, therapy animals, acupuncture and a host of other recreational activities to aid patients and/or families mentally and spiritually as they address their medical needs. Last but hardly least, it's highly rewarding knowing that while receiving such cutting edge care for myself, I'm also participating in research to optimize treatment for other patients in the future. I hope you and your family never need a place like this, but if you do, this is the place to be.

This is a Phase 3 study to evaluate the efficacy, safety, and tolerability of crinecerfont versus placebo administered for 28 weeks in approximately 81 pediatric patients with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. The study consists of a 28-week double blind, placebo-controlled period, followed by 24 weeks of treatment with crinecerfont. Duration of participation is approximately 14 months.

Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Patients With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)

This study is evaluating whether a drug may help treat a rare condition in children.

Congenital Adrenal Hyperplasia Clinical Trials

Chronocortfor Hyperplasia

Chronocortfor Hyperplasia

Crinecerfontfor Hyperplasia